Cerevel Designs a Digital Clinical Architecture
Best Practices and Lessons Learned from Cerevel's Implementation of the elluminate Clinical Data Cloud
Cerevel Designs a Digital Clinical Architecture for Modern Research with elluminate
Founded in late 2018 through a partnership with Pfizer and Bain Capital, Cerevel Therapeutics is a clinical-stage biopharmaceutical company working to transform the lives of people suffering from neuroscience diseases. As a new company with multiple clinical-stage products in development, Cerevel had the opportunity to create a new IT infrastructure without worrying about legacy systems, outdated equipment, or long-term contracts with vendors.
Challenge
With over 10 drugs in development — including therapies to treat schizophrenia, epilepsy, and Parkinson’s in late clinical trials, Cerevel was looking for innovative strategies to manage numerous data streams coming in from multiple trials. Cerevel required a technology platform that could support the volume, variety and velocity of modern clinical trials utilizing multiple CROs and system providers. They also required a system that could map and standardize the data plus enable near real-time analysis to make better business decisions faster.
Solution
After evaluating a number of solutions, Cerevel selected eClinical Solutions’ elluminate® Clinical Data Cloud, which can ingest data from multiple sources and formats. elluminate’s out-of-the box connection with Medidata Rave and overall interoperability provided Cerevel with a path to scale and the flexibility to utilize different types of DCT providers.
Results
elluminate allowed Cerevel to bring in large volumes of trial data from various CROs and systems, easily transform this information into a standardized format, and acquire robust analytics in near real-time. This gave them a high level of agility to make better decisions quickly, pivot when necessary, and spot problems before they could grow into more significant issues.
Related products
elluminate Data Central, Clinical Analytics, and CTMS Insights allowed Cerevel to bring in large volumes of trial data from various CROs and systems, easily transform this information into a standardized format and acquire robust analytics in near real-time. This gave them a high level of agility to make better decisions quickly, pivot when necessary and spot problems before they could grow into more significant issues.
Operational Insights
Manages and combines all your operational data into one source of truth that you can benefit from for both your ongoing and future trials.
Data Central
All your trial data from every source, one place for integrated review- listings, patient profiles, analytics, queries and issue management.
Clinical Analytics
Comprehensive visualizations and reporting that support safety and efficacy decisions within and across trials, operational analytics that help proactively manage your trial.
Related services
By utilizing eClinical Solutions’ elluminate Implementation services, Cerevel was able to quickly scale adoption and maximize the usage and efficiency of the platform for immediate value.
elluminate Implementation
Customized implementation services are based on your organizational data strategy and needs to ensure business transformation and ROI
“
We wanted to be digitally transformed and we really needed a centralized single version of the truth.
elluminate offered a cloud-based solution, rapid time to value with standard reports we got out of the box, and fertile ground to iterate over time based on our specific needs. Early on we needed a solution and elluminate fit that bill.
Rich Gleeson
Head of R&D Technology
Cerevel Therapeutics
Ready to take charge of your clinical data?
Schedule a demo and/or speak to an eClinical Solutions representative to learn more.
We're committed to your privacy. eClinical Solutions uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.